Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of three different lymphatic tracers used for sentinel lymph node biopsy (SLNB) procedures. The combination includes indocyanine green (ICG), methylene blue (MB), and technetium Tc 99m sulfur colloid (Tc99m). When used together, these tracers provide enhanced visualization and identification of sentinel lymph nodes, particularly in early-stage breast cancer and other cancers. Studies have shown that combining these tracers results in very high identification rates (up to 100%) compared to using single tracers alone.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on indocyanine green + methylene blue + technetium Tc 99m sulfur colloid.